Sort
1,049,261 grants matching “t cell”
Manganese exposure and genetic diversity in risk mechanisms for neurodevelopmental disorders
$2,917,964Fiona Edith Harrison · Vanderbilt University Medical Center · R01 · FY2025 · ES
Transcription Network Controlling Drosophila Development
$2,917,680Mark D Biggin · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2007 · GM
Genomics of Acute Myelogenous Leukemia
$2,917,422Timothy J Ley · Washington University · P01 · FY2017 · CA
Core Support for Cancer Center
$2,916,911Edward Chu · Albert Einstein College Of Medicine · P30 · FY2021 · CA
Core Support for Cancer Center
$2,916,911Israel David Goldman · Albert Einstein College Of Medicine · P30 · FY2019 · CA
Core Support for Cancer Center
$2,916,911Edward Chu · Albert Einstein College Of Medicine · P30 · FY2020 · CA
Integrated system for Category C infectious disease diagnostics in resource-limi
$2,916,905Darrell P Chandler · Harvard Medical School · U19 · FY2014 · AI
Scalable electron tomography for connectomics
$2,916,210Wei-Chung Allen Lee · Harvard Medical School · RF1 · FY2022 · MH
Shared Resource Management
$2,916,130M. Celeste Simon · University Of Pennsylvania · P30 · FY2021 · CA
Modulation Of Neuronal Channels and Receptors in the Brain
$2,915,682Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Transcription Network Controlling Drosophila Development
$2,915,602Mark D Biggin · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2006 · GM
Role of UCH-L1 in Ischemic Injury and Recovery
$2,915,430Steven H Graham · University Of Pittsburgh At Pittsburgh · RF1 · FY2020 · NS
Charles River Laboratories (CRL); Contract:HHSN273201500012C ; FY15 funding to fund the base contract award; CAN 8010787; IGF::OT::IGF:: Pathology Peer Review & Pathology Support for DNTP & DIR at NIE
$2,915,267James Morrison · Charles River Laboratories Intntl, Inc. · N01 · FY2017 · ES
Multilevel Influences on HIV and Substance Use in a YMSM cohort
$2,915,207Brian Mustanski · Northwestern University At Chicago · U01 · FY2021 · DA
GM-CSF-Adjuvanted Clade C DNA/MVA and MVA/MVA Vaccines
$2,915,139Harriet L Robinson · Geovax, Inc. · U19 · FY2007 · AI
Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders
$2,915,077Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Program Project in Models of Breast Cancer
$2,914,689Larry Norton · Sloan-Kettering Inst Can Research · P01 · FY2012 · CA
Program Project in Models of Breast Cancer
$2,914,687Larry Norton · Sloan-Kettering Inst Can Research · P01 · FY2011 · CA
Single Cell Resolution Omics Analysis of T1D islets
$2,914,519Charles K Ansong · Battelle Pacific Northwest Laboratories · UC4 · FY2015 · DK
PACT
$2,914,187Leslie Eric Silberstein · Immune Disease Institute, Inc. · N01 · FY2012 · HL
Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA^3CT )
$2,914,152Michael L. Terrin · University Of Maryland Baltimore · R01 · FY2011 · AG
Biological heterogeneity in ADRD
$2,913,613Thomas J. Grabowski · University Of Washington · P30 · FY2024 · AG
Moffitt Cancer Center Support Grant
$2,913,494William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2010 · CA
Measurement of HIV Neutralization Using Quantitative Assays
$2,913,225John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Project 5: mRNA and mRNA-launched nanoparticle vaccines
$2,913,088Neil King · University Of Washington · U19 · FY2024 · AI